Fisher & Paykel Healthcare Corporation Limited (FSPKF)
OTCMKTS
· Delayed Price · Currency is USD
17.48
-4.55 (-20.65%)
Mar 3, 2025, 3:00 PM EST
FSPKF Revenue
Fisher & Paykel Healthcare Corporation had revenue of 951.20M NZD in the half year ending September 30, 2024, with 37.74% growth. This brings the company's revenue in the last twelve months to 1.89B, up 11.57% year-over-year. In the fiscal year ending March 31, 2024, Fisher & Paykel Healthcare Corporation had annual revenue of 1.74B with 10.23% growth.
Revenue (ttm)
1.89B NZD
Revenue Growth
+11.57%
P/S Ratio
n/a
Revenue / Employee
268.85K NZD
Employees
7,031
Market Cap
11.15B USD
Revenue Chart
* This company reports financials in NZD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 1.74B | 161.70M | 10.23% |
| Mar 31, 2023 | 1.58B | -100.60M | -5.98% |
| Mar 31, 2022 | 1.68B | -289.50M | -14.69% |
| Mar 31, 2021 | 1.97B | 707.50M | 55.99% |
| Mar 31, 2020 | 1.26B | 193.30M | 18.06% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.79B |
| SS Innovations International | 16.04M |
| Veradigm | 1.53B |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 188.29M |
| Northwest Biotherapeutics | 1.60M |
| Silence Therapeutics | 43.26M |
| BioStem Technologies | 210.49M |
Fisher & Paykel Healthcare Corporation News
- 5 weeks ago - Trump tariffs hit the ASX with Fisher & Paykel dragged into storm - The Australian Financial Review
- 5 weeks ago - Fisher & Paykel Healthcare says US tariffs will increase costs, but sees no impact on profit - NZ Herald
- 3 months ago - Fisher & Paykel Healthcare Corp Ltd (FSPKF) (H1 2025) Earnings Call Highlights: Strong ... - GuruFocus
- 3 months ago - Half Year 2025 Fisher & Paykel Healthcare Corporation Ltd Earnings Call Transcript - GuruFocus
- 3 months ago - Fisher & Paykel misses high market hopes, sticks to guidance - The Australian Financial Review
- 3 months ago - Fisher & Paykel Healthcare Corporation Limited (FSPKF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Fisher & Paykel Healthcare Corporation Limited 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 3 months ago - Fisher & Paykel Healthcare GAAP EPS of 26.20cps, revenue of NZ$951.2M - Seeking Alpha